| Website | proteontherapeuti... |
| Category | BioTech |
| Phone | 7818900102 |
| mfitzpatrick@prot... | |
| Employees | |
| Founded | 2001 |
| Description | biopharmaceutical company |
| TOTAL | $77.2M |
| FUNDING TOTAL | $77.2M |
| Series A, 9/07 TVM Capital Skyline Ventures Prism VentureWorks InterSouth Partners | $12M |
| Series B, 5/09 Bessemer Venture Partners Devon Park BioVentures MPM Bio IV NVS Strategic Fund Vectis Healthcare & Life Sciences Fund TVM Capital Skyline Ventures Prism VentureWorks InterSouth Partners | $50M |
| Venture Round, 8/11 | $15.2M |
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.
The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.
Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures.
The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).